NL-OMON51091已完成不适用
utrition to Relieve IBS symptoms by targeting the Microbiota - NUTRIMI study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- IBS patients that meet the Rome IV criteria. This will be evaluated by the
- •medical supervisor;
- •- Male and female adults, aged 18-65 years;
- •- Having a Body Mass Index (BMI) between 18.5 and 30 kg/m2;
- •- Willing to keep a stable dietary pattern throughout the study;
- •- Having a smartphone to fill out the daily questionnaires;
排除标准
- •- Having a gastro-intestinal disease, such as celiac disease, Crohn*s disease,
- •or Ulcerative colitis;
- •- Having a history of intestinal surgery that might interfere with study
- •outcomes. This does not include an appendectomy or cholecystectomy;
- •- Having a food allergy to milk protein or pulse protein;
- •- Presence of significant systemic diseases, such as diabetes mellitus, cancer,
- •cardiovascular disease or respiratory disease;
- •- When applicable: currently pregnant or breastfeeding, or intending to become
- •pregnant during the study, as this can affect stool patterns and wellbeing;
- •- Use of antibiotic treatment less than 3 months before start of the study and
- •no use of antibiotics during the study;
- •- Use of prebiotics and/or probiotics (should be stopped 4 weeks before the
- •start of the study) and infrequent use of other (fiber) supplements. Some
- •supplements are allowed, but intake should be kept stable during the whole
- •study period (Supplements will be judged by the medical supervisor MD Ben
- •- Currently following a FODMAP-restricted diet;
- •- Use of medication that can interfere with the study outcomes, including
- •anxiolytics (antidepressants are allowed), laxatives (Over-the-counter
- •laxatives are allowed, but intake should be either stopped at least 4 weeks
- •before the start of the study or kept stable during the complete study period),
- •and codeine, as judged by the medical supervisor MD Ben Witteman;
- •- Participation in another clinical trial at the same time;
- •- Student or employee working at Food, Health and Consumer Research from
- •Wageningen Food and Biobased Research;
- •- Alcohol intake * 2 (women) or * 4 (men) glasses of alcoholic beverages per
- •Abuse of illicit drugs
- •- being incapacitated
研究者
相似试验
已完成
不适用
utrition to relieve IBS constipatioIrritable Bowel Syndrome10016950NL-OMON50958Wageningen Universiteit180
已完成
不适用
Symptom management for irritable bowel syndromeKCT0002064Semyung University Oriental Medicine Hospital24
已完成
不适用
Treating people with IBS: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome (IBS)Digestive SystemIrritable bowel syndrome (IBS)ISRCTN67764449niversity of East London (UK)40
进行中（未招募）
1 期
Ondansetron for the treatment of IBS with diarrhoea: predicting the responder.EUCTR2017-000533-31-GBottingham University Hospitals NHS Trust400
尚未招募
不适用
Treatment of irritable bowel syndrome: Using dietary carbohydrate restriction and hypnotherapy as complementary therapiesIrritable bowel syndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12612000585820Monash University78